1 Introduction 10
1.1 Industry Definition and Research Scope 10
1.1.1 Industry Definition 10
1.1.2 Research Scope 11
1.2 Research Methodology 14
1.2.1 Overview of Market Research Methodology 14
1.2.2 Market Assumption 15
1.2.3 Secondary Data 15
1.2.4 Primary Data 15
1.2.5 Data Filtration and Model Design 16
1.2.6 Market Size/Share Estimation 17
1.2.7 Research Limitations 18
1.3 Executive Summary 19
2 Market Overview and Dynamics 22
2.1 Market Size and Forecast 22
2.1.1 Impact of COVID-19 on World Economy 23
2.1.2 Impact of COVID-19 on the Market 26
2.1.3 Impact of Russia-Ukraine Conflict: War Slows Economic Recovery 28
2.2 Major Growth Drivers 32
2.3 Market Restraints and Challenges 36
2.4 Emerging Opportunities and Market Trends 39
2.5 Porter?s Fiver Forces Analysis 43
3 Segmentation of Global Market by Source 47
3.1 Market Overview by Source 47
3.2 Synthetic API 49
3.2.1 Branded Synthetic API 50
3.2.2 Generic Synthetic API 51
3.3 Semi-synthetic API 52
3.4 Natural Origin 53
4 Segmentation of Global Market by Product Type 54
4.1 Market Overview by Product Type 54
4.2 Standard API 56
4.3 High Potency API (HPAPI) 57
4.3.1 Branded HPAPI 58
4.3.2 Generic HPAPI 59
5 Segmentation of Global Market by Therapeutic Area 60
5.1 Market Overview by Therapeutic Area 60
5.2 Infectious Diseases 62
5.3 Oncology 63
5.4 Ophthalmology 64
5.5 Cardiovascular Disorders 65
5.6 Central Nervous System 66
5.7 Respiratory Disorders 67
5.8 Metabolic Diseases 68
5.9 Other Therapeutic Areas 69
6 Segmentation of Global Market by Application 70
6.1 Market Overview by Application 70
6.2 Clinical Use 72
6.3 Commercial Use 73
7 Segmentation of Global Market by Manufacturer Type 74
7.1 Market Overview by Manufacturer Type 74
7.2 Pharmaceutical Companies 76
7.3 CMOs 78
8 Segmentation of Global Market by Region 80
8.1 Geographic Market Overview 2022-2032 80
8.2 North America Market 2022-2032 by Country 84
8.2.1 Overview of North America Market 84
8.2.2 U.S. 88
8.2.3 Canada 91
8.2.4 Mexico 93
8.3 European Market 2022-2032 by Country 95
8.3.1 Overview of European Market 95
8.3.2 Germany 99
8.3.3 U.K. 101
8.3.4 France 103
8.3.5 Spain 105
8.3.6 Italy 107
8.3.7 Russia 109
8.3.8 Rest of European Market 111
8.4 Asia-Pacific Market 2022-2032 by Country 113
8.4.1 Overview of Asia-Pacific Market 113
8.4.2 Japan 117
8.4.3 China 120
8.4.4 Australia 122
8.4.5 India 124
8.4.6 South Korea 126
8.4.7 Rest of APAC Region 128
8.5 South America Market 2022-2032 by Country 130
8.5.1 Argentina 133
8.5.2 Brazil 135
8.5.3 Chile 137
8.5.4 Rest of South America Market 139
8.6 MEA Market 2022-2032 by Country 140
8.6.1 UAE 143
8.6.2 Saudi Arabia 145
8.6.3 South Africa 147
8.6.4 Other National Markets 149
9 Competitive Landscape 150
9.1 Overview of Key Vendors 150
9.2 New Product Launch, Partnership, Investment, and M&A 153
9.3 Company Profiles 154
Aurobindo Pharma Ltd. 154
Cambrex Corporation 156
Catalent Inc. 157
Dr. Reddy's Laboratories 160
GlaxoSmithKline plc 163
Lonza Group 167
Merck & Co., Inc. 170
Mylan N.V. 172
Novartis AG 174
Pfizer Inc. 176
Sun Pharmaceutical Industries Ltd. 180
Teva Pharmaceutical Industries Ltd. 183
Wuxi AppTec Co., Ltd. 185
RELATED REPORTS 187